MA26915A1 - 3-AZABICYCLO (3,1,0) HEXANE DERIVATIVES HAVING AN AFFINITY FOR OPIOID RECEPTORS. - Google Patents

3-AZABICYCLO (3,1,0) HEXANE DERIVATIVES HAVING AN AFFINITY FOR OPIOID RECEPTORS.

Info

Publication number: MA26915A1
Authority: MA; Morocco
Prior art keywords: azabicyclo; affinity; opioid receptors; hexane derivatives; hexane
Prior art date: 2000-06-23

Application number

MA26955A

Other languages

French (fr)

Inventor

Joseph Banks Bernard

Morris Gethin David

James Critcher Douglas

Paul Gibson Stephen

Edward Fenwick Ashley

Lunn Graham

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-23

Filing date

2002-12-16

Publication date

2004-12-20

2002-12-16 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26915A1 publication Critical patent/MA26915A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

MA26955A 2000-06-23 2002-12-16 3-AZABICYCLO (3,1,0) HEXANE DERIVATIVES HAVING AN AFFINITY FOR OPIOID RECEPTORS. MA26915A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0015562.2A GB0015562D0 (en)	2000-06-23	2000-06-23	Heterocycles

Publications (1)

Publication Number	Publication Date
MA26915A1 true MA26915A1 (en)	2004-12-20

Family

ID=9894368

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26955A MA26915A1 (en)	2000-06-23	2002-12-16	3-AZABICYCLO (3,1,0) HEXANE DERIVATIVES HAVING AN AFFINITY FOR OPIOID RECEPTORS.

Country Status (34)

Country	Link
EP (1)	EP1292574A1 (en)
JP (1)	JP2004512263A (en)
KR (1)	KR20040002386A (en)
CN (1)	CN1639121A (en)
AP (1)	AP2002002698A0 (en)
AR (1)	AR028969A1 (en)
AU (1)	AU781837B2 (en)
BG (1)	BG107329A (en)
BR (1)	BR0111867A (en)
CA (1)	CA2412188A1 (en)
CZ (1)	CZ20023967A3 (en)
DO (1)	DOP2001000187A (en)
DZ (1)	DZ3368A1 (en)
EA (1)	EA005117B1 (en)
GB (1)	GB0015562D0 (en)
HR (1)	HRP20020998A2 (en)
HU (1)	HUP0301228A3 (en)
IL (1)	IL153427A0 (en)
IS (1)	IS6637A (en)
MA (1)	MA26915A1 (en)
MX (1)	MXPA02012878A (en)
NO (1)	NO20026168L (en)
NZ (1)	NZ523141A (en)
OA (1)	OA12293A (en)
PA (1)	PA8519401A1 (en)
PE (1)	PE20020253A1 (en)
PL (1)	PL365956A1 (en)
SK (1)	SK17172002A3 (en)
TN (1)	TNSN01094A1 (en)
UA (1)	UA73176C2 (en)
UY (1)	UY26787A1 (en)
WO (1)	WO2001098267A1 (en)
YU (1)	YU91802A (en)
ZA (1)	ZA200210278B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2463264C (en)	2001-10-22	2009-05-26	Pfizer Products Inc.	3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
EP1505974B1 (en) *	2002-05-17	2009-04-22	Tioga Pharmaceuticals, Inc.	Use of compounds that are effective as selective opiate receptor modulators
DE10259245A1 (en)	2002-12-17	2004-07-01	Merck Patent Gmbh	Derivatives of asimadolin with covalently bound acids
AU2005215918C1 (en) *	2004-02-23	2010-01-21	Glaxo Group Limited	Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
GB0507680D0 (en) *	2005-04-15	2005-05-25	Glaxo Group Ltd	Compounds
JP5068747B2 (en) *	2005-06-14	2012-11-07	グラクソグループリミテッド	Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
WO2007113258A1 (en) *	2006-04-03	2007-10-11	Glaxo Group Limited	Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors
PT2136801E (en)	2007-03-30	2012-12-06	Tioga Pharmaceuticals Inc	Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
TWI423801B (en) *	2007-08-27	2014-01-21	Theravance Inc	8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
WO2011154827A2 (en)	2010-06-11	2011-12-15	Rhodes Technologies	Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
JP2013542929A (en)	2010-09-28	2013-11-28	パナセアバイオテックリミテッド	New bicyclo ring compounds
MX2016006482A (en)	2013-11-20	2016-12-09	Sanwa Kagaku Kenkyusho Co	Novel 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purposes.
CA2985327A1 (en)	2015-05-20	2016-11-24	Sanwa Kagaku Kenkyusho Co., Ltd.	Crystal of salt of 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof
EP3582783B1 (en)	2017-02-17	2023-06-07	Trevena, Inc.	7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CA3052480A1 (en) *	2017-02-17	2018-08-23	Trevena, Inc.	5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
AU2018229062A1 (en)	2017-03-02	2019-09-26	Ube Industries, Ltd.	Therapeutic agent for alcohol use disorders
CN108250088B (en) *	2018-01-04	2020-10-30	四川之江高新材料股份有限公司	Preparation method of N, N, N '-trimethyl-N' -hydroxyethyl bisaminoethylether
CN115825305B (en) *	2022-10-21	2024-09-20	昆明理工大学	Molecularly imprinted solid-phase microextraction fiber and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3065230A (en) *	1959-03-16	1962-11-20	Burroughs Wellcome Co	Azabicyclohexanes and method of preparing them
PH24752A (en) *	1987-04-16	1990-10-01	Lilly Co Eli	Piperidine opioid antagonists
US5159081A (en) *	1991-03-29	1992-10-27	Eli Lilly And Company	Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (en) *	1993-12-04	1995-06-08	Basf Ag	N-substituted 3-azabicycloalkane derivatives, their preparation and use
PE20001420A1 (en) *	1998-12-23	2000-12-18	Pfizer	CCR5 MODULATORS
TWI244481B (en) *	1998-12-23	2005-12-01	Pfizer	3-azabicyclo[3.1.0]hexane derivatives useful in therapy

2000
- 2000-06-23 GB GBGB0015562.2A patent/GB0015562D0/en not_active Ceased
2001
- 2001-06-06 DO DO2001000187A patent/DOP2001000187A/en unknown
- 2001-06-07 HR HR20020998A patent/HRP20020998A2/en not_active Application Discontinuation
- 2001-06-07 WO PCT/IB2001/001035 patent/WO2001098267A1/en not_active Ceased
- 2001-06-07 MX MXPA02012878A patent/MXPA02012878A/en unknown
- 2001-06-07 EA EA200201269A patent/EA005117B1/en not_active IP Right Cessation
- 2001-06-07 EP EP01936728A patent/EP1292574A1/en not_active Withdrawn
- 2001-06-07 DZ DZ013368A patent/DZ3368A1/en active
- 2001-06-07 OA OA1200200386A patent/OA12293A/en unknown
- 2001-06-07 HU HU0301228A patent/HUP0301228A3/en unknown
- 2001-06-07 AP APAP/P/2002/002698A patent/AP2002002698A0/en unknown
- 2001-06-07 CZ CZ20023967A patent/CZ20023967A3/en unknown
- 2001-06-07 KR KR1020027017503A patent/KR20040002386A/en not_active Ceased
- 2001-06-07 CA CA002412188A patent/CA2412188A1/en not_active Abandoned
- 2001-06-07 NZ NZ523141A patent/NZ523141A/en unknown
- 2001-06-07 CN CNA018116086A patent/CN1639121A/en active Pending
- 2001-06-07 PL PL01365956A patent/PL365956A1/en not_active Application Discontinuation
- 2001-06-07 BR BR0111867-6A patent/BR0111867A/en not_active IP Right Cessation
- 2001-06-07 AU AU62591/01A patent/AU781837B2/en not_active Ceased
- 2001-06-07 IL IL15342701A patent/IL153427A0/en unknown
- 2001-06-07 SK SK1717-2002A patent/SK17172002A3/en unknown
- 2001-06-07 YU YU91802A patent/YU91802A/en unknown
- 2001-06-07 JP JP2002504223A patent/JP2004512263A/en not_active Withdrawn
- 2001-06-12 PA PA20018519401A patent/PA8519401A1/en unknown
- 2001-06-21 AR ARP010102957A patent/AR028969A1/en unknown
- 2001-06-21 PE PE2001000604A patent/PE20020253A1/en not_active Application Discontinuation
- 2001-06-21 UY UY26787A patent/UY26787A1/en not_active Application Discontinuation
- 2001-06-22 TN TNTNSN01094A patent/TNSN01094A1/en unknown
- 2001-07-06 UA UA20021210406A patent/UA73176C2/en unknown
2002
- 2002-11-28 IS IS6637A patent/IS6637A/en unknown
- 2002-11-28 BG BG107329A patent/BG107329A/en unknown
- 2002-12-16 MA MA26955A patent/MA26915A1/en unknown
- 2002-12-19 ZA ZA200210278A patent/ZA200210278B/en unknown
- 2002-12-20 NO NO20026168A patent/NO20026168L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AP2002002698A0 (en)	2002-12-31
AU781837B2 (en)	2005-06-16
WO2001098267A1 (en)	2001-12-27
HUP0301228A2 (en)	2003-08-28
BG107329A (en)	2003-07-31
GB0015562D0 (en)	2000-08-16
KR20040002386A (en)	2004-01-07
BR0111867A (en)	2003-07-01
PA8519401A1 (en)	2002-12-30
UY26787A1 (en)	2002-01-31
IS6637A (en)	2002-11-28
CN1639121A (en)	2005-07-13
PE20020253A1 (en)	2002-04-08
JP2004512263A (en)	2004-04-22
DOP2001000187A (en)	2002-03-30
HUP0301228A3 (en)	2005-08-29
CA2412188A1 (en)	2001-12-27
PL365956A1 (en)	2005-01-24
TNSN01094A1 (en)	2005-11-10
EA005117B1 (en)	2004-10-28
MXPA02012878A (en)	2003-05-14
OA12293A (en)	2004-03-18
EP1292574A1 (en)	2003-03-19
SK17172002A3 (en)	2004-09-08
YU91802A (en)	2006-05-25
NZ523141A (en)	2005-06-24
HRP20020998A2 (en)	2004-02-29
IL153427A0 (en)	2003-07-06
AU6259101A (en)	2002-01-02
DZ3368A1 (en)	2001-12-27
NO20026168D0 (en)	2002-12-20
WO2001098267A8 (en)	2003-02-27
ZA200210278B (en)	2003-12-19
UA73176C2 (en)	2005-06-15
NO20026168L (en)	2003-02-18
AR028969A1 (en)	2003-05-28
CZ20023967A3 (en)	2004-02-18
EA200201269A1 (en)	2003-06-26

Publication	Publication Date	Title
MA26915A1 (en)	2004-12-20	3-AZABICYCLO (3,1,0) HEXANE DERIVATIVES HAVING AN AFFINITY FOR OPIOID RECEPTORS.
ATE335725T1 (en)	2006-09-15	3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS
BR0216099B1 (en)	2013-12-03	"WEAR SET".
ATE354570T1 (en)	2007-03-15	5,6-DIARYL-PYRAZINEAMIDE DERIVATIVES AS CB1 ANTAGONISTS
ZA991413B (en)	1999-08-30	Substituted quinoxaline derivatives as interleukin-8 receptor antagonists.
MA27032A1 (en)	2004-12-20	NEW INDOLE AFFINITY DERIVATIVES FOR THE 5-HT6 RECEPTOR
AU2001243345A1 (en)	2001-09-12	1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
AP2004003007A0 (en)	2004-06-30	3-Azabicyclo (3.1.0) hexane derivatives as oploid receptor antagonists.
MXPA03006991A (en)	2003-11-18	Piperidinee derivatives as neurokinin 1 antagonists.
AR028248A1 (en)	2003-04-30	NEW COMPOUNDS 2,3,4,5-TETRAHIDRO-1H- (1,4) DIAZEPINO (1,7-A) INDOL
FR2860427B1 (en)	2007-11-16	HUMERAL INSERT FOR AN INVERSE SHOULDER PROSTHESIS.
FR2817858B1 (en)	2003-02-07	PROCESS FOR THE INERTAGE OF AN ASH, ARTIFICIAL POUZZOLANE OBTAINED BY SAID PROCESS
MXPA03003892A (en)	2003-07-28	Bombesin receptor antagonists.
IT1318674B1 (en)	2003-08-27	DO IT FOR INCONTINENCE.
EP1248617A4 (en)	2003-03-05	NEW NMDA / NR2B ANTAGONISTS OF 2-AZA-BICYCLO 2.2.2] OCTANE
MXPA03008441A (en)	2004-01-29	Dgr;1.
MXPA03009930A (en)	2004-01-29	Crf receptor antagonists.
FR2814041B1 (en)	2010-07-30	TUTORING COLLAR FOR TREES
IT249333Y1 (en)	2003-04-14	FOLDING TRIANGLE FOR STATIONARY VEHICLE SIGNALING.
SE9800815D0 (en)	1998-03-13	Bio-chelating agents, high affinity bio-target antagonists
ITSA20010001A0 (en)	2001-01-19	"SECTIONAL FEEDER FLOAT".
IT1321131B1 (en)	2003-12-30	ANTENNA GROUP FOR VEHICLES.
IT1304821B1 (en)	2001-04-05	CONTAINER-PROGRAMMER FOR TAKING DRUGS.
HK1068617A (en)	2005-04-29	5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
HK1062301A (en)	2004-10-29	3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists